Litigation Details for HUMANA INC. v. CELGENE CORPORATION (D.N.J. 2019)
✉ Email this page to a colleague
HUMANA INC. v. CELGENE CORPORATION (D.N.J. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-02-28 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 15:1 Antitrust Litigation | Assigned To | Esther Salas |
Jury Demand | Plaintiff | Referred To | Michael A. Hammer |
Patents | 7,141,018; 7,189,740; 7,465,800; 7,668,730; 7,855,217; 7,968,569; 8,315,886; 8,404,717; 8,530,498; 8,648,095; 9,056,120; 9,101,621; 9,101,622 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in HUMANA INC. v. CELGENE CORPORATION
Biologic Drugs cited in HUMANA INC. v. CELGENE CORPORATION
Details for HUMANA INC. v. CELGENE CORPORATION (D.N.J. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-02-28 | 1 | Complaint | restricting access to ‘018 Patent 7,141,018 3-Jan-05 23-Oct-20 …800 patent, ‘217 patent, ‘569 patent, ‘498 patent, ‘095 patent, ‘621 patent, and the ‘622 patent. 92 …800 patent, ‘217 patent, ‘569 patent, ‘498 patent, ‘095 patent, ‘621 patent, and the ‘622 patent. 93 …‘501 patent, the ‘976 patent, the ‘432 patent, the ‘984 patent, the ‘763 patent, the ‘188 patent, the …‘720 patent, the ‘977 patent, the ‘784 patent, the ‘399 patent, the ‘018 patent, the ‘566 patent, the | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |